(Q46407845)

21 December 2017

title

Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma (English)

1 reference

21 December 2017

0 references

1 reference

1 reference

Philippe Paparel

1

1 reference

21 December 2017

Laura Curiel

2

1 reference

21 December 2017

Sabrina Chesnais

3

1 reference

21 December 2017

Rene Ecochard

4

1 reference

21 December 2017

Jean-Yves Chapelon

5

1 reference

21 December 2017

Albert Gelet

6

1 reference

21 December 2017

publication date

1 April 2005

1 reference

21 December 2017

published in

BJU International

1 reference

21 December 2017

volume

95

1 reference

21 December 2017

issue

6

1 reference

21 December 2017

page(s)

881-885

1 reference

21 December 2017

Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Chemotherapy for advanced hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Effects of high-intensity focused ultrasound in the treatment of experimental neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

High-Intensity Focused Ultrasound in the Treatment of Experimental Liver Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Tumor irradiation with intense ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Thermal dose determination in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Sonodynamic antitumour effect of chloroaluminum phthalocyanine tetrasulfonate on murine solid tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Treatment of transplanted adriamycin-resistant ovarian cancers in mice by combination of adriamycin and ultrasound exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Activity of docetaxel with or without estramustine phosphate versus mitoxantrone in androgen dependent and independent human prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2005.05420.X

10.1111/J.1464-410X.2005.05420.X

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017